STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy.

Details

Language :

English

ISSN :

1120009X

Volume :

36

Issue :

1

Database :

Academic Search Index

Journal :

Journal of Chemotherapy (Taylor & Francis Ltd)

Publication Type :

Academic Journal

Accession number :

175035050

Full Text :

https://doi.org/10.1080/1120009X.2023.2203610